These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 24288264
21. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection]. Toro de Méndez M, Ferrández Izquierdo A, Llombart-Bosch A. Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523 [Abstract] [Full Text] [Related]
22. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance. Ding Z, Li Y, Chen A, Song M, Zhang Y. Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739 [Abstract] [Full Text] [Related]
23. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Int J Med Sci; 2013 Dec; 10(12):1602-7. PubMed ID: 24151431 [Abstract] [Full Text] [Related]
24. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N. J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802 [Abstract] [Full Text] [Related]
25. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing. Zhang G, Yang B, Abdul-Karim FW. Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189 [Abstract] [Full Text] [Related]
28. Management of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years. Ryu KJ, Lee S, Min KJ, Hong JH, Song JY, Lee JK, Lee NW. Diagn Cytopathol; 2016 Dec; 44(12):959-963. PubMed ID: 27714942 [Abstract] [Full Text] [Related]
29. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia. Walts AE, Lechago J, Bose S. Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320 [Abstract] [Full Text] [Related]
30. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions. Zhang R, Ge X, You K, Guo Y, Guo H, Wang Y, Geng L. J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887 [Abstract] [Full Text] [Related]
31. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Schmidt D, Bergeron C, Denton KJ, Ridder R, European CINtec Cytology Study Group. Cancer Cytopathol; 2011 Jun 25; 119(3):158-66. PubMed ID: 21442767 [Abstract] [Full Text] [Related]
32. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China. Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL. Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033 [Abstract] [Full Text] [Related]
33. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Ekalaksananan T, Pientong C, Sriamporn S, Kongyingyoes B, Pengsa P, Kleebkaow P, Kritpetcharat O, Parkin DM. Gynecol Oncol; 2006 Oct 19; 103(1):62-6. PubMed ID: 16494930 [Abstract] [Full Text] [Related]
34. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)]. Zhan X, Wang S, Wu X, Qiu X, Li F, Zeng Y, Chen Z. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct 19; 34(10):937-941. PubMed ID: 30554588 [Abstract] [Full Text] [Related]
35. Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis. Chen CC, Huang LW, Bai CH, Lee CC. Ann Saudi Med; 2016 Oct 19; 36(4):245-51. PubMed ID: 27478909 [Abstract] [Full Text] [Related]
36. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A. BJOG; 2004 Aug 19; 111(8):842-8. PubMed ID: 15270934 [Abstract] [Full Text] [Related]
37. Cytohistological discrepancies of cervico-vaginal smears and HPV status. Alanbay İ, Öztürk M, Fıratlıgil FB, Karaşahin KE, Yenen MC, Bodur S. Ginekol Pol; 2017 Aug 19; 88(5):235-238. PubMed ID: 28580567 [Abstract] [Full Text] [Related]
38. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems. Pirog EC, Erroll M, Harigopal M, Centeno BA. Arch Pathol Lab Med; 2004 May 19; 128(5):527-32. PubMed ID: 15086283 [Abstract] [Full Text] [Related]
39. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases]. Yu J, Zhu HT, Zhao JJ, Su JZ, Xia YD. Zhonghua Bing Li Xue Za Zhi; 2017 May 08; 46(5):323-326. PubMed ID: 28468038 [Abstract] [Full Text] [Related]
40. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis. Cao L, Sun PL, Yao M, Chen S, Gao H. Hum Pathol; 2017 Jul 08; 65():194-200. PubMed ID: 28554573 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]